Historically, COVID-19 symptoms have been fevers or chills, cough, shortness of breath, cough, congestion or a runny nose, ...

COVID-19 is still raging, and we're seeing an especially high surge of it in winter 2025—plus high rates of flu, RSV and even ...

New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA™ (pemivibart) against XEC Centers for Disease ...

THE historic massive landslide victory of Donald J. Trump in all sectors of the American electorate last November gave the 47th president of the United States a clear resounding ...

There have been 334 deaths attributed to COVID since July, 2024. Doctors in Massachusetts, and around the country say that the best way to fight the new COVID variant called "XEC" is to get the latest ...

and pipeline candidate VYD2311 against dominant SARS-CoV-2 variant XEC. As anticipated based on the structural biology of pemivibart and VYD2311, the data are largely consistent with those ...

Highlights,PEMGARDA™ shows sustained neutralizing activity against the XEC variant, covering 69% of U.S. variants.,The drug has demonstrated effectiveness against over 75% of circulating U.S. variants ...

XEC became the dominant COVID strain this month. Scientists have been predicting this strain for a while. The CDC stated that XEC has caused 45% of all SARS-2 COVID-19 infections since Dec. 8th.

Invivyd's new data highlights Pemgarda's activity against SARS-CoV-2 XEC and over 75% of variants, with consistent neutralization since Omicron BA.1.

Leading the charge now silently—because viruses don’t talk—is the XEC variant of the SARS-CoV-2. The Centers for Disease Control and Prevention estimated that the XEC variant has comprised ...

The most common, dominant COVID variant as 2024 comes to a close is XEC, according to the Centers for Disease Control and Yale Medicine. XEC stems from a combination of two previous Omicron ...